Evidence map›Paper›PMID 28577183›Full record

ArticleJournal of assisted reproduction and genetics2017

Evaluation of comprehensive chromosome screening platforms for the detection of mosaic segmental aneuploidy.

David Goodrich, Tongji Xing, Xin Tao, Agnieszka Lonczak, Yiping Zhan, Jessica Landis, Rebekah Zimmerman, Richard T Scott, Nathan R Treff

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Whole exome sequencing: a new era in prenatal diagnostics.Journal of translational medicine · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David GoodrichReproductive Medicine Associates of New Jersey, 140 Allen Rd, Basking Ridge, NJ, 07920, USA.
Tongji XingReproductive Medicine Associates of New Jersey, 140 Allen Rd, Basking Ridge, NJ, 07920, USA.
Xin TaoFoundation for Embryonic Competence, 140 Allen Rd, Suite 300, Basking Ridge, NJ, 07920, USA.
Agnieszka LonczakFoundation for Embryonic Competence, 140 Allen Rd, Suite 300, Basking Ridge, NJ, 07920, USA.
Yiping ZhanFoundation for Embryonic Competence, 140 Allen Rd, Suite 300, Basking Ridge, NJ, 07920, USA.
Jessica LandisFoundation for Embryonic Competence, 140 Allen Rd, Suite 300, Basking Ridge, NJ, 07920, USA.
Rebekah ZimmermanFoundation for Embryonic Competence, 140 Allen Rd, Suite 300, Basking Ridge, NJ, 07920, USA.
Richard T ScottReproductive Medicine Associates of New Jersey, 140 Allen Rd, Basking Ridge, NJ, 07920, USA.
Nathan R TreffReproductive Medicine Associates of New Jersey, 140 Allen Rd, Basking Ridge, NJ, 07920, USA. ntreff@rmanj.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA subset of preimplantation embryos identified as euploid may in fact possess both whole and sub-chromosomal mosaicism, raising concerns regarding the predictive value of current comprehensive chromosome screening (CCS) methods utilizing a single biopsy. Current CCS methods may be capable of detecting sub-chromosomal mosaicism in a trophectoderm biopsy by examining intermediate levels of segmental aneuploidy within a biopsy. This study evaluates the sensitivity and specificity of segmental aneuploidy detection by three commercially available CCS platforms utilizing a cell line mixture model of segmental mosaicism in a six-cell trophectoderm biopsy.

methodsTwo cell lines with known karyotypes were obtained and mixed together at specific ratios of six total cells (0:6, 1:5, 2:4, 3:3, 4:2, 5:1, and 6:0). A female cell line containing a 16.2 Mb deletion on chromosome 5 and a male cell line containing a 25.5 Mb deletion on chromosome 4 were used to create mixtures at each level. Six replicates of each mixture were prepared, randomized, and blinded for analysis by one of the three CCS platforms (SNP-array, VeriSeq NGS, or NexCCS). Sensitivity and specificity of segmental aneuploidy at each level of mosaicism was determined and compared between each platform. Additionally, an alternative VeriSeq NGS analysis method utilizing previously published criteria was evaluated.

resultsExamination of the default settings of each platform revealed that the sensitivity was significantly different between NexCCS and SNP up to 50% mosaicism, custom VeriSeq, and SNP-array up to 66% mosaicism, and between NexCCS and custom VeriSeq up to 50% mosaicism. However, no statistical difference was observed in mixtures with >50% mosaicism with any platform. No comparison was made between default VeriSeq, as it does not report segmental imbalances. Furthermore, while the use of previously published criteria for VeriSeq NGS significantly increased sensitivity at low levels of mosaicism, a significant decrease in specificity was observed (66% false positive prediction of segmental aneuploidy).

conclusionThese results demonstrate the potential of NGS-based detection methods to detect segmental mosaicism within a biopsy. However, these data also demonstrate that a balance between sensitivity and specificity should be more carefully considered. These results emphasize the importance of vigorous preclinical evaluation of new testing criteria prior to clinical implementation providing a point of departure for further algorithm development and improved detection of mosaicism within preimplantation embryos.

Indexed as

AneuploidyBiopsyBlastocystCell LineChromosomesEmbryo TransferFemaleGenetic TestingHumansMaleMosaicismPreimplantation DiagnosisSensitivity and SpecificityComprehensive chromosome screeningMosaicismNext generation sequencingPreimplantation genetic screeningSegmental aneuploidy

Identifiers

PMID28577183
PMCPMC5533675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.